⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Oncostrata and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Oncostrata
↗London, United Kingdom
Oncostrata is a specialized clinical science and data management consultancy focused exclusively on oncology and hematology. The company provides expert guidance to biotech and pharmaceutical clients across the full lifecycle of clinical development, including study design, medical data review, CRO oversight, and regulatory documentation for health authority submissions.
Headquartered in London, the company operates as a niche service provider, integrating its PhD- and MD-level scientists into client cross-functional teams. They support various therapeutic modalities, including small molecule inhibitors, immunotherapies, and cell-based therapies, helping sponsors navigate the complexities of cancer clinical trials.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Oncology Clinical Development Consultancy
SIZE & FINANCIALS
Employees:1-50
Revenue:$0.5M-$1M
Founded:2010
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Modalities:Small molecule, Immunotherapy, Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Kadans Science Partner (Joined London Innovation Centre in 2025)
COMPETITION
Position:Niche Player
Competitors:Novartis, Catalent, Surrozen
LEADERSHIP
Key Executives:
Joanna Hanks - Founder and Head of Clinical Science
Scientific Founders:Joanna Hanks
LINKS
Website:oncostrata.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Oncostrata. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.